A Study of MZE782 in Adults With PKU
Recruiting
Phase 2
Interventional Study
Phenylketonuria (PKU)
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 38 (estimated)
- Sponsor
- Maze Therapeutics · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion Criteria:
* Males and females 18 to 75 years old
* Clinical diagnosis of PKU
* Willing and able to keep diet and protein intake consistent during the study
* For some study groups, is willing and able to stop certain PKU medications before starting study treatment
* For some study gro…
Contacts